Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.

Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol. 2020 04; 203(4):684-689.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents
Carcinoma, Renal Cell
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Disease-Free Survival
Female
Follow-Up Studies
Humans
Kidney
Kidney Neoplasms
Male
Middle Aged
Multicenter Studies as Topic
Neoplasm Recurrence, Local
Neoplasm Staging
Nephrectomy
Prognosis
Prospective Studies
Randomized Controlled Trials as Topic
Risk Assessment

authors with profiles

CHRISTOPHER G WOOD